Literature DB >> 18445708

Novel interaction of the dopamine D2 receptor and the Ca2+ binding protein S100B: role in D2 receptor function.

Yong Liu1, David C Buck, Kim A Neve.   

Abstract

S100B is a calcium-binding protein with both extracellular and intracellular regulatory activities in the mammalian brain. We have identified a novel interaction between S100B and the dopamine D(2) receptor. Our results also suggest that the binding of S100B to the dopamine D(2) receptor enhances receptor signaling. This conclusion is based on the following observations: 1) S100B and the third cytoplasmic loop of the dopamine D(2) receptor interact in a bacterial two-hybrid system and in a poly-histidine pull-down assay; 2) immunoprecipitation of the D(2) receptor also precipitates FLAG-S100B from human embryonic kidney 293 cell homogenates and endogenous S100B from rat neostriatal homogenates; 3) S100B immunoreactivity was detected in cultured neostriatal neurons expressing the D(2) receptor; 4) a putative S100B binding motif is located at residues 233 to 240 of the D(2) receptor, toward the amino terminus of the third cytoplasmic loop. D(3)-IC3, which does not bind S100B, does not contain this motif; and 5) coexpression of S100B in D(2) receptor-expressing 293 cells selectively increased D(2) receptor stimulation of extracellular signal-regulated kinases and inhibition of adenylate cyclase.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18445708      PMCID: PMC2574776          DOI: 10.1124/mol.108.044925

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  37 in total

Review 1.  Dopamine receptor signaling.

Authors:  Kim A Neve; Jeremy K Seamans; Heather Trantham-Davidson
Journal:  J Recept Signal Transduct Res       Date:  2004-08       Impact factor: 2.092

Review 2.  The pathways connecting G protein-coupled receptors to the nucleus through divergent mitogen-activated protein kinase cascades.

Authors:  J S Gutkind
Journal:  J Biol Chem       Date:  1998-01-23       Impact factor: 5.157

3.  Identification of a Zn2+-binding site on the dopamine D2 receptor.

Authors:  Yong Liu; Martha M Teeter; Curtiss J DuRand; Kim A Neve
Journal:  Biochem Biophys Res Commun       Date:  2006-01-20       Impact factor: 3.575

Review 4.  Indirect modulation of dopamine D2 receptors as potential pharmacotherapy for schizophrenia: I. Adenosine agonists.

Authors:  D A Dixon; L A Fenix; D M Kim; R B Raffa
Journal:  Ann Pharmacother       Date:  1999-04       Impact factor: 3.154

5.  S100B protein is released from rat neonatal neurons, astrocytes, and microglia by in vitro trauma and anti-S100 increases trauma-induced delayed neuronal injury and negates the protective effect of exogenous S100B on neurons.

Authors:  Earl F Ellis; Karen A Willoughby; Sallie A Sparks; Tao Chen
Journal:  J Neurochem       Date:  2007-04-02       Impact factor: 5.372

6.  S100A1 and S100B expression and target proteins in type I diabetes.

Authors:  D B Zimmer; J Chessher; G L Wilson; W E Zimmer
Journal:  Endocrinology       Date:  1997-12       Impact factor: 4.736

7.  Dopamine D2 receptor stimulation of mitogen-activated protein kinases mediated by cell type-dependent transactivation of receptor tyrosine kinases.

Authors:  Chunhe Wang; David C Buck; Rui Yang; Tara A Macey; Kim A Neve
Journal:  J Neurochem       Date:  2005-05       Impact factor: 5.372

8.  G protein-mediated mitogen-activated protein kinase activation by two dopamine D2 receptors.

Authors:  E Y Choi; D Jeong; K W Park; J H Baik
Journal:  Biochem Biophys Res Commun       Date:  1999-03-05       Impact factor: 3.575

9.  Evidence that calmodulin binding to the dopamine D2 receptor enhances receptor signaling.

Authors:  Yong Liu; David C Buck; Tara A Macey; Hongxiang Lan; Kim A Neve
Journal:  J Recept Signal Transduct Res       Date:  2007       Impact factor: 2.092

Review 10.  Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type.

Authors:  R Donato
Journal:  Biochim Biophys Acta       Date:  1999-07-08
View more
  19 in total

1.  Dopamine D2 receptor signaling modulates mutant ataxin-1 S776 phosphorylation and aggregation.

Authors:  Scoty M Hearst; Mariper E Lopez; Qingmei Shao; Yong Liu; Parminder J S Vig
Journal:  J Neurochem       Date:  2010-04-30       Impact factor: 5.372

Review 2.  Dopamine D2 autoreceptor interactome: Targeting the receptor complex as a strategy for treatment of substance use disorder.

Authors:  Rong Chen; Mark J Ferris; Shiyu Wang
Journal:  Pharmacol Ther       Date:  2020-05-27       Impact factor: 12.310

3.  Glial S100B protein modulates mutant ataxin-1 aggregation and toxicity: TRTK12 peptide, a potential candidate for SCA1 therapy.

Authors:  Parminder J S Vig; Scoty Hearst; Qingmei Shao; Mariper E Lopez; Henry A Murphy; Eshan Safaya
Journal:  Cerebellum       Date:  2011-06       Impact factor: 3.847

4.  Effects of environmental enrichment on ERK1/2 phosphorylation in the rat prefrontal cortex following nicotine-induced sensitization or nicotine self-administration.

Authors:  Adrian M Gomez; Wei-Lun Sun; Narasimha M Midde; Steven B Harrod; Jun Zhu
Journal:  Eur J Neurosci       Date:  2014-10-18       Impact factor: 3.386

5.  S100B Serum Levels in Schizophrenia Are Presumably Related to Visceral Obesity and Insulin Resistance.

Authors:  Johann Steiner; Aye Mu Myint; Kolja Schiltz; Sabine Westphal; Hans-Gert Bernstein; Martin Walter; Matthias L Schroeter; Markus J Schwarz; Bernhard Bogerts
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-06-10

Review 6.  Functions of S100 proteins.

Authors:  R Donato; B R Cannon; G Sorci; F Riuzzi; K Hsu; D J Weber; C L Geczy
Journal:  Curr Mol Med       Date:  2013-01       Impact factor: 2.222

Review 7.  Emerging role of S100B protein implication in Parkinson's disease pathogenesis.

Authors:  Efthalia Angelopoulou; Yam Nath Paudel; Christina Piperi
Journal:  Cell Mol Life Sci       Date:  2020-10-14       Impact factor: 9.261

8.  S100 calcium binding proteins and ion channels.

Authors:  Anton Hermann; Rosario Donato; Thomas M Weiger; Walter J Chazin
Journal:  Front Pharmacol       Date:  2012-04-25       Impact factor: 5.810

9.  Evaluation of Substituted N-Phenylpiperazine Analogs as D3 vs. D2 Dopamine Receptor Subtype Selective Ligands.

Authors:  Boeun Lee; Michelle Taylor; Suzy A Griffin; Tamara McInnis; Nathalie Sumien; Robert H Mach; Robert R Luedtke
Journal:  Molecules       Date:  2021-05-26       Impact factor: 4.927

10.  Levels of S100B are raised in female patients with schizophrenia.

Authors:  Kara O'Connell; Jogin Thakore; Kumlesh K Dev
Journal:  BMC Psychiatry       Date:  2013-05-24       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.